Incyte Corporation

(INCY)

By |

Profile

Incyte Corp is a biopharmaceutical company. It discovers, develops and commercializes proprietary small molecule drugs to treat serious unmet medical needs, mainly in oncology.

Contact Information

Website: www.incyte.com
Email: pmurphy@incyte.com
Main Phone: +1 302 498-6700
Address: 1801 Augustine Cut-Off
State: DE
City / Town: Wilmington
Country: USA
Postal Code: 19803

Issuer Information

Exchange: NGS
Employees: 692
NAICS: 541711
$ 134.02 $ 2.81 (2.14%)
Last Price 134.02 Change $ 2.81 Change % 2.14 Tick N/A
Bid 133.54 Bid Size 500.00 Ask N/A Ask Size 0.00
Open 131.88 High 134.97 Low 130.24 Prev Close 131.21
Last Trade Volume 33.2 mi 52 Wk Hi 134.97 52 Wk Low 60.30
Market Cap 25.4 bi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 189,408,381.00 EPS (TTM) 0.54 PE Ratio 243.00 Exchange NGS
  Last 3 Mo Last 12 Mo
Number of Insider Trades 18 158
Number of Buys 16 136
Number of Sells 2 22
Net Activity 54285 8773288
Last 10 Buys Shares
Julian C. Baker 1,000
Julian C. Baker 1,000
Julian C. Baker 1,000
Julian C. Baker 1,000
Julian C. Baker 1,000
Julian C. Baker 1,000
Julian C. Baker 1,000
Julian C. Baker 1,000
Julian C. Baker 1,000
Julian C. Baker 1,000
Last 10 Sell Shares
Reid M. Huber 1,000
Paula J. Swain 1,000
Paula J. Swain 1,000
Richard S. Levy 1,000
Eric H. Siegel 1,000
Richard S. Levy 1,000
Paul A. Friedman 1,000
Paul A. Friedman 1,000
Paul A. Friedman 1,000
Paul A. Friedman 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 135 135 135 135
Low Target Price Estimate 90 85 76 90
Mean Target Price Estimate 100.82 97.27 93.9 100.55
Standard Deviation 12.46 14.62 16.31 12.47
Date of Most Recent Estimate 08/10/16 08/04/16 07/19/16 08/19/16
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 10 9 11 11
Moderate Buy 2 2 1 1
Hold 1 1 1 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.27 1.29 1.19 1.19